Key facts
- This page summarizes Dinesh M. Kumar's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Mar 2022, 16:26.
Dinesh M. Kumar - 08 Mar 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- ALHC
- Reported as of
- 08 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Mar 2022, 16:26:49 UTC
- Prior SEC filing
- 24 Nov 2021
- Next SEC filing
- 01 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard A. Cross, as Attorney-in-Fact, for Dinesh M. Kumar
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dinesh M. Kumar filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 10 Mar 2022.
Change
- Previous filing in this sequence was filed on 24 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +206,954
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 1,194,028
- Date
- 08 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALHC
transaction
Derivative
Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +152,068
- Change %
- Price
- $0.000000
- Shares after
- 152,068
- Date
- 08 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 152,068
- Exercise price
- $9.06
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents 206,954 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company.
Footnote F2
Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.